Method validation and reconnaissance of pharmaceuticals, personal care products, and alkylphenols in surface waters, sediments, and mussels in an urban estuary.

Novel methods utilizing liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry were validated for low-level detection of 104 pharmaceuticals and personal care products ingredients (PPCPs) and four alkylphenols (APs) in environmental samples. The methods were applied to surface water, sediment, and mussel tissue samples collected from San Francisco Bay, CA, USA, an urban estuary that receives direct discharge from over forty municipal and industrial wastewater outfalls. Among the target PPCPs, 35% were detected in at least one sample, with 31, 10, and 17 compounds detected in water, sediment, and mussels, respectively. Maximum concentrations were 92 ng/L in water (valsartan), 33 ng/g dry weight (dw) in sediments (triclocarban), and 14 ng/g wet weight (ww) in mussels (N,N-diethyl-m-toluamide). Nonylphenol was detected in water (<2-73 ng/L), sediments (22-86 ng/g dw), and mussels (<0.04-95 ng/g ww), and nonylphenol mono- and diethoxylates were detected in sediments (<1-40 ng/g dw) and mussels (<5-192 ng/g ww). The concentrations of PPCPs and APs detected in the San Francisco Bay samples were generally at least an order of magnitude below concentrations expected to elicit toxic effects in aquatic organisms. This study represents the first reconnaissance of PPCPs in mussels living in an urban estuary and provides the first field-derived bioaccumulation factors (BAFs) for select compounds in aquatic organisms.

[1]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002, Environmental science & technology.

[2]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .

[3]  Kristin A Connors,et al.  Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows. , 2012, Environmental science & technology.

[4]  Q. Cass,et al.  Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal). , 2010, The Science of the total environment.

[5]  Caiming Tang,et al.  Multiresidue Determination of Sulfonamides, Macrolides, Trimethoprim, and Chloramphenicol in Sewage Sludge and Sediment Using Ultrasonic Extraction Coupled with Solid Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry , 2009 .

[6]  Sushil K. Khetan,et al.  Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry. , 2007, Chemical reviews.

[7]  N. Hayden,et al.  Nonylphenol in the Environment: a Critical Review , 2022 .

[8]  V. Andreu,et al.  Determination of pharmaceuticals in soils and sediments by pressurized liquid extraction and liquid chromatography tandem mass spectrometry. , 2010, Journal of chromatography. A.

[9]  J. Meador,et al.  Environmental Contaminants in Biota : Interpreting Tissue Concentrations, Second Edition , 2011 .

[10]  A. David,et al.  Alkylphenols in marine environments: distribution monitoring strategies and detection considerations. , 2009, Marine pollution bulletin.

[11]  J. Ritchie,et al.  Fate of triclosan and evidence for reductive dechlorination of triclocarban in estuarine sediments. , 2008, Environmental science & technology.

[12]  D. Barceló,et al.  Multi-residue method for trace level determination of pharmaceuticals in solid samples using pressurized liquid extraction followed by liquid chromatography/quadrupole-linear ion trap mass spectrometry. , 2009, Talanta.

[13]  K. Fent,et al.  Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.

[14]  Kristin A Connors,et al.  Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing. , 2012, Reviews of environmental contamination and toxicology.

[15]  S. Zaugg,et al.  Pressurized liquid extraction using water/isopropanol coupled with solid-phase extraction cleanup for industrial and anthropogenic waste-indicator compounds in sediment , 2005 .

[16]  Kyungho Choi,et al.  Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions? , 2012, Environmental health perspectives.

[17]  Benjamin D. Stanford,et al.  Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. , 2009, Environmental science & technology.

[18]  S. Snyder,et al.  Toxicological relevance of pharmaceuticals in drinking water. , 2010, Environmental science & technology.

[19]  Guido Fink,et al.  Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass Spectrometry. , 2006, Environmental science & technology.

[20]  K. Scow,et al.  Effects of ciprofloxacin on salt marsh sediment microbial communities , 2007, The ISME Journal.

[21]  Bryan W Brooks,et al.  Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. , 2010, Toxicology letters.

[22]  J. Brausch,et al.  A review of personal care products in the aquatic environment: environmental concentrations and toxicity. , 2011, Chemosphere.

[23]  D. Kolpin,et al.  Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. , 2010, Environmental science & technology.

[24]  K. Carlson,et al.  Temporal and spatial trends in the occurrence of human and veterinary antibiotics in aqueous and river sediment matrices. , 2007, Environmental science & technology.

[25]  Alejandro J. Ramirez,et al.  Occurrence of pharmaceuticals and personal care products in fish: Results of a national pilot study in the united states , 2009, Environmental toxicology and chemistry.

[26]  J. Nichols,et al.  Evaluation of log KOW and tissue lipid content as predictors of chemical partitioning to fish tissues , 1998 .

[27]  K. Thomas,et al.  The occurrence of selected human pharmaceutical compounds in UK estuaries. , 2004, Marine pollution bulletin.

[28]  D. Kolpin,et al.  Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination. , 2005, Environmental science & technology.

[29]  K. Thomas,et al.  Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment. , 2011, Journal of environmental monitoring : JEM.

[30]  Wenjing Fu,et al.  Methods for estimating the bioconcentration factor of ionizable organic chemicals , 2009, Environmental toxicology and chemistry.

[31]  S. Weigel,et al.  Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. , 2002, The Science of the total environment.

[32]  J. Zhou,et al.  Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone. , 2011, Journal of hazardous materials.

[33]  J. Lazorchak,et al.  Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. , 2008, Analytical chemistry.

[34]  Juan Luis Santos,et al.  Multi-residue method for the analysis of pharmaceutical compounds in sewage sludge, compost and sediments by sonication-assisted extraction and LC determination. , 2010, Journal of separation science.

[35]  Jörg Römbke,et al.  Environmental fate of pharmaceuticals in water/sediment systems. , 2005, Environmental science & technology.

[36]  Alejandro J. Ramirez,et al.  Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry. , 2007, Analytical chemistry.

[37]  E. Michael Thurman,et al.  Response to Comment on “Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999−2000: A National Reconnaissance” , 2002 .

[38]  Frank A. P. C. Gobas,et al.  A review of bioconcentration factor (BCF) and bioaccumulation factor (BAF) assessments for organic chemicals in aquatic organisms , 2006 .

[39]  C. Daughton "Active Pharmaceutical Ingredients and Aquatic Organisms" Chapter in: Bayer N and Meador J. (eds) Environmental Contaminants in Biota: Interpreting Tissue Concentrations, 2nd Ed. Taylor and Francis , 2010 .

[40]  Hélène Budzinski,et al.  Multi-residue analysis of pharmaceutical compounds in aqueous samples. , 2008, Journal of chromatography. A.

[41]  J. Readman,et al.  Inhibition of barnacle settlement by the environmental oestrogen 4-nonylphenol and the natural oestrogen 17β oestradiol , 1998 .

[42]  T. Ternes,et al.  Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.

[43]  M. Waiser,et al.  Effluent‐dominated streams. Part 2: Presence and possible effects of pharmaceuticals and personal care products in Wascana Creek, Saskatchewan, Canada , 2011, Environmental toxicology and chemistry.

[44]  T. Ternes,et al.  Analysis and sorption of psychoactive drugs onto sediment. , 2008, Environmental science & technology.

[45]  Alejandro J. Ramirez,et al.  Determination of select antidepressants in fish from an effluent‐dominated stream , 2005, Environmental toxicology and chemistry.

[46]  R. Dinsdale,et al.  Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination. , 2009, Environmental pollution.

[47]  M. Benotti,et al.  Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. , 2007, Environmental science & technology.

[48]  T. Ternes Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .

[49]  M. Benotti,et al.  Microbial degradation of pharmaceuticals in estuarine and coastal seawater. , 2009, Environmental pollution.

[50]  A. Chaudhary,et al.  Occurrence and distribution of steroids, hormones and selected pharmaceuticals in South Florida coastal environments , 2010, Ecotoxicology.

[51]  S. M. Howard,et al.  Use of distribution coefficients in quantitative structure-activity relationships. , 1977, Journal of medicinal chemistry.

[52]  D. Kolpin,et al.  A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States--II) untreated drinking water sources. , 2008, The Science of the total environment.

[53]  Roman Ashauer,et al.  Uptake and depuration of pharmaceuticals in aquatic invertebrates. , 2012, Environmental pollution.

[54]  D. Muir,et al.  Occurrence of triclosan in plasma of wild Atlantic bottlenose dolphins (Tursiops truncatus) and in their environment. , 2009, Environmental pollution.

[55]  T. Newton,et al.  Environmental occurrence and reproductive effects of the pharmaceutical fluoxetine in native freshwater mussels , 2010, Environmental toxicology and chemistry.

[56]  Ran Tao,et al.  Simultaneous determination of four classes of antibiotics in sediments of the Pearl Rivers using RRLC-MS/MS. , 2010, The Science of the total environment.

[57]  Colin R. Janssen,et al.  Validation and application of an LC-MS/MS method for the simultaneous quantification of 13 pharmaceuticals in seawater , 2010, Analytical and bioanalytical chemistry.

[58]  Barbara Kasprzyk-Hordern,et al.  The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. , 2008, Water research.

[59]  T. L. Point,et al.  Snail bioaccumulation of triclocarban, triclosan, and methyltriclosan in a north texas, usa, stream affected by wastewater treatment plant runoff , 2008, Environmental toxicology and chemistry.